Browse U.S. telehealth providers and peptide therapeutics across six therapeutic categories. Providers are scored on methodology v4.1 (seven weighted categories, 100 points); scores from the May 2026 review (v3.0 rubric) are shown until re-scoring is complete.
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.
Telehealth providers are not interchangeable across therapeutic categories. A GLP-1-focused provider like NexLife has very different operational requirements (pharmacy traceability, physician oversight on titration, cardiovascular safety review) than a longevity provider that dispenses NAD+ or epithalon (research-grade peptides, lab integration for biomarkers). Match the provider to the use case.
Editorial team
Researched by Dr. Parmis (Editorial Lead); medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). About our team →